A patient at St. Franziskus Hospital in Germany was the first to undergo a procedure using W.L. Gore & Associates' Tag Conformable Thoracic Stent Graft after the device was granted CE mark approval by European regulators in June. The device, which enables controlled, staged deployment using a new delivery system, is intended for enhancing accuracy, apposition and angulation in the treatment of aneurysms, acute and chronic Type B dissections and other etiologies of the descending thoracic aorta.
First commercial use of Tag thoracic stent graft recorded by W.L. Gore
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.